PharmaCyte Biotech, Inc.
PMCBNasdaqCIK 1157075HealthcareFiscal year ends Apr 30
Reports and events: 211 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2009-09-1710:53 ET | 10-Q | Quarterly reportPeriod 2009-07-31 | 0001262463-09-000075 |
| 2009-09-1516:53 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001262463-09-000074 |
| 2009-09-1416:46 ET | 10-Q | Quarterly reportPeriod 2009-04-30 | 0001262463-09-000073 |
| 2009-08-1316:05 ET | 10-K | Annual reportPeriod 2009-04-30 | 0001262463-09-000065 |
| 2009-04-0616:39 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001262463-09-000030 |
| 2009-03-2615:46 ET | 8-K | 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001262463-09-000022 |
| 2009-03-1715:04 ET | 10-Q | Quarterly reportPeriod 2009-01-31 | 0001262463-09-000021 |
| 2009-03-0419:06 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity | 0001262463-09-000019 |
| 2009-02-1813:06 ET | 8-K/A | 1.01 Entry into a material agreement | 0001262463-09-000014 |
| 2009-02-1709:09 ET | 8-K | 1.01 Entry into a material agreement | 0001262463-09-000012 |
| 2009-01-1614:25 ET | 8-K | 1.01 Entry into a material agreement | 0001262463-09-000004 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:52 ET. Listed shows no prices and gives no investment advice.